Assessment of Point of Care Testing devices for infectious disease surveillance, prevention and control

Medical devices on grey background, photo by New Africa/Adobe Stock

New Africa/Adobe Stock

Background

Diagnosis of infectious diseases is a time-sensitive matter due to their ability to spread and the rapid course of infection. Delays in diagnosis can be fatal, and result in patients being treated with non-specific antimicrobials, which in turn contributes to the overall problem of antimicrobial resistance (AMR).

While newer and more rapid technologies, such as point of care testing devices (POCT), provide faster access to results and allow for more rapid clinical decision making, these are generally not available in rural settings.

Goals

RAND Europe has been commissioned by the European Centre for Disease Prevention and Control (ECDC) to provide an overview of available POCT devices and their use regarding the 56 communicable diseases and related health issues currently under EU surveillance.

Methodology

The project will include:

  1. A scoping review to obtain an overview of the availability and use of POCT covering the 56 communicable diseases and related health issues currently under EU surveillance.
  2. A mapping exercise to assess the current status and trends in the use of POCT in EU/EEA countries.
  3. A technical meeting with experts to assess the existing and potential future impact of POCT use in the EU/EEA on public health key functions.

Related Research